The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jevremovic, D.
Right arrow Articles by Leibson, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jevremovic, D.
Right arrow Articles by Leibson, P. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
The Journal of Immunology, 1999, 162: 2453-2456.
Copyright © 1999 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: A Role for the Adaptor Protein LAT in Human NK Cell-Mediated Cytotoxicity1

Dragan Jevremovic*, Daniel D. Billadeau*, Renee A. Schoon*, Christopher J. Dick*, Brenda J. Irvin*, Weiguo Zhang{dagger}, Lawrence E. Samelson{dagger}, Robert T. Abraham* and Paul J. Leibson2,*

* Department of Immunology, Mayo Clinic and Foundation, Rochester, MN 55905; and {dagger} Section on Lymphocyte Signaling, Cell Biology and Metabolism Branch, National Institutes of Health, Bethesda, MD 20892


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
Stimulation of NK cell-mediated cytotoxicity involves the coupling of proximal Src and Syk family protein tyrosine kinases to downstream effectors. However, the mechanisms linking these second messenger pathways are incompletely understood. Here, we describe a key role for the LAT (p36) adaptor protein in human NK cell activation. LAT is tyrosine phosphorylated upon stimulation of NK cells through Fc{gamma}RIII receptors and following direct contact with NK-sensitive target cells. This NK stimulation induces the association of LAT with several phosphotyrosine-containing proteins. In addition to the biochemical evidence showing LAT involvement in NK cell activation, a genetic model shows that LAT is required for FcR-dependent phosphorylation of phospholipase C-{gamma}. Furthermore, overexpression of LAT in NK cells leads to increased Ab-dependent cell-mediated cytotoxicity and "natural cytotoxicity," thus demonstrating a functional role for LAT in NK cells. These data suggest that LAT is an important adaptor protein for the regulation of human NK cell-mediated cytotoxicity.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Natural killer cells are a subpopulation of CD16+, CD56+ large granular lymphocytes 1 . They have multiple immune functions, including mediation of resistance to intracellular microbial infections, control of tumor growth, and regulation of inflammatory responses. Unlike B and T lymphocytes, NK cells do not express Ag-specific receptors. Rather, their activation is initiated by the Fc{gamma}RIII receptor (Ab-dependent cell-mediated cytotoxicity (ADCC)3) or, in a less defined manner, through a direct interaction with certain malignant or virus-infected target cells ("natural cytotoxicity") 2 .

The biologic functions of NK cells differ from the functions of other lymphocyte subpopulations, e.g., B and T cells. However, the mechanism of NK activation bears homology to that employed by other lymphocytes. Although B cell receptor, TCR, and FcR differ in their extracellular portions, these multichain immune recognition receptors (MIRR) all have immunoreceptor tyrosine-based activation motifs in their signal-transducing subunits and all share certain common features in their intracellular signaling pathways 3 . Fc{gamma}RIII cross-linking on NK cells leads to the activation of Src and Syk family kinases 4, 5, 6 . Downstream of Syk family kinases are, among other molecules, phospholipase C-{gamma} (PLC-{gamma}) 7, 8, 9 , the guanine nucleotide exchange factor Vav 10 , and the adaptor protein SLP76 11, 12, 13 , all of which are important regulators of NK cell-mediated cytotoxicity 7, 8, 14, 15 .

Early studies of lymphocyte signaling showed that an ~36-kDa protein undergoes tyrosine phosphorylation upon stimulation of T and NK cells 16, 17, 18, 19 . Recently, this protein was cloned from T cells and named linker for activation of T cells (LAT) 20 . This protein lacks intrinsic catalytic activity, but it appears to function as an adaptor integrating signals initiated by MIRR stimulation. LAT is a transmembrane protein and has multiple tyrosine residues that, upon phosphorylation, promote specific protein-protein interactions with Src homology (SH)-2-containing proteins. Palmitoylation of LAT seems to be important for its targeting to glycolipid-enriched membrane subdomains in which specific interactions with other proteins may occur 21 . Upon TCR cross-linking, phosphorylated LAT associates with several signaling proteins such as PLC-{gamma}1, Vav, SLP76, Grb2, and the p85 subunit of the phosphatidylinositol 3-kinase (PI3K) 20 . A LAT mutant bearing substitutions at the two C-terminal tyrosine residues fails to associate with specific interacting proteins, suggesting that the full adaptor function of LAT is dependent on the inducible tyrosine phosphorylation of this protein. Moreover, the same LAT mutant inhibits TCR-induced transcriptional activity of AP-1 and NFAT when transiently expressed in Jurkat T cells. Therefore, phosphorylated LAT seems to be playing a role in the nucleation of several signaling complexes important for T cell activation.

The function of LAT in NK cells is unknown. Phosphorylated p36 has been implicated as a direct target of the killer cell inhibitory receptor-associated phosphatase SHP-1 during inhibitory signaling in NK cells 19 . Phosphorylated p36 has also been found to bind to the adaptor protein Grb2 during the FcR stimulation of NK cells 18, 22 . This association may be involved in the activation of downstream effectors such as Ras and phosphatidylinositol 3-kinase. However, the precise role for LAT during NK cell activation and particularly its potential role in NK cell-mediated cytotoxicity have not been described. In this paper, we provide genetic, biochemical, and functional evidence that supports a key role for LAT in the regulation of human NK cell-mediated cytotoxicity.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Cell lines and reagents

Unless otherwise indicated, all chemicals were obtained from Sigma (St. Louis, MO). Human NK clones were cloned and passaged as previously described 23 . Briefly, CD16+ PBL from healthy donors were cloned by limiting dilution in RPMI 1640 supplemented with 10% human serum and 20 U/ml of IL-2. Freshly isolated PBMC were obtained from healthy human donors and were monocyte-depleted by adhesion to tissue-culture flasks. The human Jurkat T cell line, murine mastocytoma line P815, and anti-CD3-producing hybridoma OKT3 (murine IgG2a) were obtained from American Type Culture Collection (Manassas, VA). The HLA class I-deficient C1R and 721.221 cell lines were kindly provided by Peter Cresswell (Yale University, New Haven, CT) and Peter Parham (Stanford University, Palo Alto, CA), respectively. The LAT-deficient ANJ3 clone was derived by selection of randomly mutagenized Jurkat E6 cells for stable somatic mutants bearing defects in TCR-induced Ca2+ mobilization 24 . Anti-phosphotyrosine mAb 4G10 was purchased from Upstate Biotechnology (Lake Placid, NY). Rabbit polyclonal antiserum to LAT was obtained by immunization of rabbits with keyhole limpet hemocyanin-conjugated LAT peptide (amino acids 106–131). Polyclonal antisera to Vav, SLP-76, and PLC-{gamma}1 have been previously described (Refs. 14, 15, and 7, respectively).

Cell stimulation

Cells were stimulated as previously described 25 and lysed in buffer containing 20 mM Tris-HCl, 40 mM NaCl, 5 mM EDTA, 50 mM NaF, 30 mM Na4P2O7, 0.1% BSA, 1 mM Na3VO4, 1 mM PMSF, 5 µg/ml aprotinin, 5 µg/ml leupeptin, and 1% Triton X-100 (pH 7.4). Insoluble material was removed by centrifugation for 5 min at 14,000 rpm. Cell lysates were subjected to immunoprecipitation for 1–2 h with the indicated rabbit antiserum bound to protein A-Sepharose beads. Eluted proteins were resolved by SDS-PAGE and transferred electrophoretically to Immobilon-P membranes (Millipore, Bedford, MA). Tyrosine phosphorylated proteins were detected with 4G10 mAb, followed by sheep anti-mouse IgG coupled to horseradish peroxidase (Amersham, Buckinghamshire, England) and with the enhanced chemiluminescence detection system (Amersham). LAT, PLC-{gamma}1, SLP76, and Vav were analyzed with specific rabbit antisera and detected with protein A-horseradish peroxidase.

Vaccinia viruses

Recombinant vaccinia viruses encoding myc-tagged, wild-type LAT (myc.LAT wt), a double tyrosine mutant (myc.LAT Y171/191F), CD16, and {gamma} constructs were made as previously described 14 . Cells (2 x 106/ml) were infected at a multiplicity of infection of 20:1 for 1 h in serum-free RPMI 1640 at 37°C and then for the remainder of the indicated infection time at 106 cells/ml in RPMI 1640 supplemented with 10% bovine calf serum.

Cytotoxicity assays

The Cr51-release assays measuring direct NK cell-mediated cytotoxicity or reverse ADCC were performed as previously described 23 .


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
The role of LAT as an adaptor protein in TCR-initiated signaling depends on its ability to become tyrosine phosphorylated upon T cell stimulation 20 . Since tyrosine phosphorylation of a 36-kDa protein has been detected after NK cell stimulation 18, 19 , we were interested in testing the potential involvement of LAT in signaling by NK cells. For that purpose, human NK cell clones were stimulated with anti-Fc{gamma}RIII Ab (3G8) for the indicated periods of time, and the phosphotyrosine content of LAT-immunoprecipitates was detected. As shown in Fig. 1GoA, LAT is tyrosine phosphorylated rapidly upon FcR cross-linking, with the peak phosphorylation at about 1 min and decreasing toward baseline by 5–10 min. Similar results were obtained using freshly isolated PBL (Fig. 1GoB) or polyclonal, "rested" (IL-2-deprived) NK cell lines (data not shown). The rapid phosphorylation of LAT upon FcR stimulation corresponds in time to the activation of other proximal signaling molecules such as Src and Syk family kinases. As shown by Zhang et al. 20 , LAT can be a substrate for Syk family kinases Syk and ZAP70, both of which are expressed in NK cells and activated following Fc{gamma}RIII stimulation 5, 6 .



View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 1. LAT is phosphorylated upon activation of NK cells. Cloned human NK cells (1 x 107/sample; A and C) or freshly isolated PBL (3 x 107/sample; B) were incubated with the anti-Fc{gamma}RIII Ab (A and B) or with NK-sensitive C1R target cells (C) for the indicated period of time. Target cells do not express the LAT protein ("alone"). LAT immunoprecipitates from lysates (1% Triton X-100) were subjected to SDS-PAGE and, upon transfer to the membrane, probed with anti-phosphotyrosine or anti-LAT Ab.

 
We next evaluated whether LAT is utilized in signaling that leads to the "natural cytotoxicity." Natural cytotoxicity is a function of the receptor-ligand interaction between NK and target cells. However, the nature of specific molecules involved in this interaction is, for the most part, not known. To test a possible involvement of LAT in signaling from these yet unidentified receptors, NK cells were stimulated directly with the tumor target cells. As with the Fc{gamma}RIII cross-linking, stimulation of NK cells with HLA class I-deficient, NK-sensitive C1R cells led to an increase in the tyrosine phosphorylation of LAT (Fig. 1GoC), although the kinetics of LAT phosphorylation were somewhat slower. Similar results were obtained when NK cells were stimulated with 721.221 NK-sensitive target cells (data not shown). The above experiments suggest that LAT is involved in signaling pathways leading to ADCC and certain forms of "natural cytotoxicity." However, it needs to be emphasized that since the triggering receptors on NK cells utilized during natural cytotoxicity have been incompletely characterized, different NK-sensitive targets may potentially initiate different sets of second messengers.

Following TCR stimulation of T cells, LAT associates with a number of signaling molecules, including PLC-{gamma} and Grb2 20 . We also detected coimmunoprecipitation of LAT with PLC-{gamma} following NK cell stimulation with anti-FcR Ab (data not shown). Association of LAT with PLC-{gamma} implied its potential role in coupling receptor stimulation to PLC-{gamma} tyrosine phosphorylation. To test if LAT is necessary for the activation of PLC-{gamma}, we used a LAT-deficient Jurkat subline, ANJ3, as a genetic model (Fig. 2GoA). Wild-type Jurkat, ANJ3, or ANJ3 cells reconstituted with the myc-tagged wild-type LAT (ANJ3-wt65, ANJ3-wt67) were infected with CD16- and {gamma}-encoding recombinant vaccinia viruses. Fc{gamma}RIII was equally expressed on the surface of each of the T cell lines (data not shown). Stimulation of ANJ3 cells through Fc{gamma}RIII or TCR leads to the tyrosine phosphorylation of multiple cellular proteins, similarly to the stimulation of parental Jurkat cells (Fig. 2GoB). However, although LAT does not seem to be required for the phosphorylation of many of the signaling proteins (SLP-76 and ZAP-70, for example), a selective loss of phosphorylation is detected for a band that migrates in the same position as PLC-{gamma}1. To confirm the identity of this band as PLC-{gamma}1, we repeated the experiment using PLC-{gamma}1 immunoprecipitates. As shown in Fig. 2GoC, PLC-{gamma}1 is tyrosine phosphorylated upon stimulation of Jurkat cells (lanes 2 and 3). This inducible phosphorylation is completely blocked in the LAT-deficient ANJ3 cells (lanes 5 and 6). Reconstitution of the wild-type LAT into ANJ3 cells rescues the phosphorylation of PLC-{gamma}1 (lanes 8 and 9). These results directly demonstrate the regulatory role of LAT in the activation of PLC-{gamma} induced by the TCR and Fc{gamma}RIII receptors.



View larger version (37K):
[in this window]
[in a new window]
  		FIGURE 2. LAT is required for TCR- and FcR-initiated phosphorylation of PLC-{gamma}. A, Jurkat, ANJ3, or stable LAT-transfected ANJ3 (ANJ3-wt65, ANJ-wt67) cells (3 x 106/sample) were lysed, and LAT-immunoprecipitates were subjected to SDS-PAGE, transferred to a membrane, and probed with anti-LAT Ab. B and C, The same cell lines were infected for 6 h with CD16- and FcR{gamma}-expressing recombinant vaccinia viruses. Nonstimulated, anti-Fc{gamma}RIII- or anti-CD3-stimulated cells were lysed in 1% Triton X-100, and whole cell lysates (B) or anti-PLC-{gamma}1 immunoprecipitates (C) were subjected to SDS-PAGE, transferred to a membrane, and probed with anti-phosphotyrosine or anti-PLC-{gamma}1 Ab.

 
We next wanted to functionally test the potential role of LAT in NK cell cytotoxicity. NK cells were infected with vaccinia viruses encoding the wild-type (LAT wt) or the double tyrosine mutant of LAT previously shown to block AP-1- and NFAT cell-dependent transcription in T cells (LAT.Y171/191F; LAT.2YF) 20 . Equal expression of the two LAT constructs was demonstrated by Western blot analysis with the anti-LAT Ab (data not shown). The effect of LAT overexpression on NK cell cytotoxicity was tested against the murine mastocytoma P815 cells bearing anti-Fc{gamma}R mAb (reverse ADCC; Fig. 3Go) or against NK-sensitive cell lines C1R (Fig. 3Go) and 721.221 (data not shown). Overexpression of the wild-type LAT, but not the Y171/191F mutant increases cytotoxicity of NK cells in the reverse ADCC and "natural cytotoxicity" assays (Fig. 3GoA). However, some variations between different NK clones were observed (Fig. 3GoB). Among potential explanations for the observed variations are differences in receptor densities or levels of LAT expression between different NK clones.



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 3. Overexpression of the wild-type but not the tyrosine mutant of LAT enhances NK cytotoxicity. NK clones were infected for 6 h with LAT wt or LAT.2YF-expressing recombinant vaccinia viruses or with the wild-type vaccinia virus as a control. Cr51-labeled target cells (104/well, with 150 ng/ml of anti-Fc{gamma}RIII Ab for P815 target cells) were incubated for 4 h with infected NK cells at the indicated E:T ratio. The release of Cr51 into the supernatant was determined, and the results are expressed as percent specific cytotoxicity (A) or as lytic units per 106 target cells (B).

 
The results of cytotoxicity assays support the regulatory role of LAT in NK cell signaling. However, the mechanism by which overexpression of an adaptor protein increases NK cytotoxicity is not clear. It is likely that clustering of signaling molecules upon receptor cross-linking results in the cellular activation only when a threshold level of mobilized downstream molecules is reached. Since LAT interacts with multiple signaling proteins (Ref. 20 and data not shown), the positive effect of LAT overexpression on NK cytotoxicity may be due to a more rapid kinetics of mobilization of key downstream effectors to the receptor complex. In contrast to the transcriptional activation of Jurkat T cells, in most of our clones LAT.2YF did not have a "dominant-negative" effect on cytotoxicity, which implies that different cellular functions may depend on different activation kinetics or different sets of second messengers.

Another potential function of LAT is the regulation of inhibitory signaling in NK cells. Interaction with MHC class I-expressing target cells led to dephosphorylation of p36 and prevented its association with PLC-{gamma} and adaptor protein Grb2 19 . The loss of association between PLC-{gamma} and p36 corresponded with diminished IP3 production but did not influence phosphorylation of PLC-{gamma} upon stimulation, thus implicating spatial restraints as a mechanism of regulating PLC-{gamma} activity. In other studies, PLC-{gamma} was found to be dephosphorylated upon killer cell inhibitory receptor engagement 26, 27 . Thus, the regulation of signals initiated by the inhibitory receptors on NK cells and the potential role of LAT in inhibitory signaling are not resolved.

In this paper, we have shown through biochemical and functional assays the importance of LAT for the activation of human NK cells. The role of the association of LAT with other signaling proteins, as well as the exact place of LAT in the signaling cascade from MIRRs, awaits future investigations.


   Footnotes
 
1 This research was supported by the Mayo Foundation and by National Institutes of Health Grant CA-47752. D.D.B. is supported by National Institutes of Health Postdoctoral Training Grant CA-09441. Back

2 Address correspondence and reprint requests to Dr. Paul J. Leibson, Department of Immunology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. E-mail address: Back

3 Abbreviations used in this paper: ADCC, Ab-dependent cell-mediated cytotoxicity; PLC, phospholipase C; MIRR, multichain immune recognition receptors. Back

Received for publication October 30, 1998. Accepted for publication December 30, 1998.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Trinchieri, G.. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.[Medline]
  2. Leibson, P. J.. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655.[Medline]
  3. Keegan, A. D., W. E. Paul. 1992. Multichain immune recognition receptors: similarities in structure and signaling pathways. Immunol. Today 13:63.[Medline]
  4. Einspahr, K. J., R. T. Abraham, B. A. Binstadt, Y. Uehara, P. J. Leibson. 1991. Tyrosine phosphorylation provides an early and requisite signal for the activation of natural killer cell cytotoxic function. Proc. Natl. Acad. Sci. USA 88:6279.[Abstract/Free Full Text]
  5. Vivier, E., A. J. da Silva, M. Ackerly, H. Levine, C. E. Rudd, P. Anderson. 1993. Association of a 70-kDa tyrosine phosphoprotein with the CD16:{zeta}:{gamma} complex expressed in human natural killer cells. Eur. J. Immunol. 23:1872.[Medline]
  6. Stahls, A., G. E. Liwszyc, C. Couture, T. Mustelin, L. C. Andersson. 1994. Triggering of human natural killer cells through CD16 induces tyrosine phosphorylation of the p72syk kinase. Eur. J. Immunol. 24:2491.[Medline]
  7. Ting, A. T., L. M. Karnitz, R. A. Schoon, R. T. Abraham, P. J. Leibson. 1992. Fc{gamma} receptor activation induces the tyrosine phosphorylation of both phospholipase C (PLC)-{gamma}1 and PLC-{gamma}2 in natural killer cells. J. Exp. Med. 176:1751.[Abstract/Free Full Text]
  8. Azzoni, L., M. Kamoun, T. W. Salcedo, P. Kanakaraj, B. Perussia. 1992. Stimulation of Fc {gamma} RIIIA results in phospholipase C-{gamma} 1 tyrosine phosphorylation and p56lck activation. J. Exp. Med. 176:1745.[Abstract/Free Full Text]
  9. Kolanus, W., C. Romeo, B. Seed. 1993. T cell activation by clustered tyrosine kinases. Cell 74:171.[Medline]
  10. Deckert, M., S. Tartare-Deckert, C. Couture, T. Mustelin, A. Altman. 1996. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product. Immunity 5:591.[Medline]
  11. Fang, N., D. G. Motto, S. E. Rossa, G. A. Koretzky. 1996. Tyrosines 113, 128, and 145 of SLP-76 are required for optimal augmentation of NFAT promoter activity. J. Immunol. 157:3769.[Abstract]
  12. Wardenburg, J. B., C. Fu, J. K. Jackman, H. Flotow, R. Jonson, G. Kong, A. C. Chan, P. R. Findell. 1996. Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function. J. Biol. Chem. 271:19641.[Abstract/Free Full Text]
  13. Musci, M. A., D. G. Motto, S. E. Ross, N. Fang, G. A. Koretzky. 1997. Three domains of SLP-76 are required for its optimal function in a T cell line. J. Immunol. 159:1639.[Abstract]
  14. Billadeau, D. D., K. M. Brumbaugh, C. J. Dick, R. A. Schoon, X. R. Bustelo, P. J. Leibson. 1998. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing. J. Exp. Med. 188:549.[Abstract/Free Full Text]
  15. Binstadt, B. A., D. D. Billadeau, D. Jevremovic, B. L. Williams, N. Fang, T. Yi, G. A. Koretzky, R. T. Abraham, P. J. Leibson. 1998. SLP-76 is a direct substrate of SHP-1 recruited to killer cell inhibitory receptors. J. Biol. Chem. 273:27518.[Abstract/Free Full Text]
  16. June, C. H., M. C. Fletcher, J. A. Ledbetter, L. E. Samelson. 1990. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation. J. Immunol. 144:1591.[Abstract]
  17. Buday, L., S. E. Egan, P. Rodriguez Viciana, D. A. Cantrell, J. Downward. 1994. A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in Ras activation in T cells. J. Biol. Chem. 269:9019.[Abstract/Free Full Text]
  18. Galandrini, R., G. Palmieri, M. Piccoli, L. Frati, A. Santoni. 1996. CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells. J. Exp. Med. 183:179.[Abstract/Free Full Text]
  19. Valiante, N. M., J. H. Phillips, L. L. Lanier, P. Parham. 1996. Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-{gamma} signaling complex in human natural killer (NK) cells. J. Exp. Med. 184:2243.[Abstract/Free Full Text]
  20. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83.[Medline]
  21. Zhang, W., R. P. Trible, L. E. Samelson. 1998. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9:239.[Medline]
  22. Cerboni, C., A. Gismondi, G. Palmieri, M. Piccoli, L. Frati, A. Santoni. 1998. CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 PI-3K subunit. Eur. J. Immunol. 28:1005.[Medline]
  23. Windebank, K. P., R. T. Abraham, G. Powis, R. A. Olsen, T. J. Barna, P. J. Leibson. 1988. Signal transduction during human natural killer cell activation: inositol phosphate generation and regulation by cyclic AMP. J. Immunol. 141:3951.[Abstract]
  24. Williams, B. L., K. L. Schreiber, W. Zhang, R. L. Wange, L. E. Samelson, P. J. Leibson, R. T. Abraham. 1998. Genetic evidence for differential coupling of Syk family kinases to the T-cell receptor: reconstitution studies in a ZAP-70-deficient Jurkat T-cell line. Mol. Cell. Biol. 18:1388.[Abstract/Free Full Text]
  25. Brumbaugh, K. M., B. A. Binstadt, D. D. Billadeau, R. A. Schoon, C. J. Dick, R. M. Ten, P. J. Leibson. 1997. Functional role for Syk tyrosine kinase in natural killer cell-mediated cytotoxicity. J. Exp. Med. 186:1965.[Abstract/Free Full Text]
  26. Brumbaugh, K. M., J. J. Perez-Villar, C. J. Dick, R. A. Schoon, M. Lopez-Botet, P. J. Leibson. 1996. Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses. J. Immunol. 157:2804.[Abstract]
  27. Binstadt, B. A., K. M. Brumbaugh, C. J. Dick, A. M. Scharenberg, B. L. Williams, M. Colonna, L. Lanier, J. P. Kinet, R. T. Abraham, P. J. Leibson. 1996. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5:629.[Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
F. Guimont-Desrochers, Z. J. Cappello, M. Chagnon, M. McDuffie, and S. Lesage
Cutting Edge: Genetic Characterization of IFN-Producing Killer Dendritic Cells
J. Immunol., May 1, 2009; 182(9): 5193 - 5197.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. C. Whittaker, D. N. Burshtyn, S. J. Orr, L. Quigley, D. L. Hodge, V. Pascal, W. Zhang, and D. W. McVicar
Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire
Blood, October 1, 2008; 112(7): 2869 - 2877.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
E. Vivier, J. A. Nunes, and F. Vely
Natural Killer Cell Signaling Pathways
Science, November 26, 2004; 306(5701): 1517 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Klem, P. C. Verrett, V. Kumar, and J. D. Schatzle
2B4 Is Constitutively Associated with Linker for the Activation of T Cells in Glycolipid-Enriched Microdomains: Properties Required for 2B4 Lytic Function
J. Immunol., July 1, 2002; 169(1): 55 - 62.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. M. Vyas, H. Maniar, and B. Dupont
Cutting Edge: Differential Segregation of the Src Homology 2-Containing Protein Tyrosine Phosphatase-1 Within the Early NK Cell Immune Synapse Distinguishes Noncytolytic from Cytolytic Interactions
J. Immunol., April 1, 2002; 168(7): 3150 - 3154.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Y. Djeu, K. Jiang, and S. Wei
A View to a Kill: Signals Triggering Cytotoxicity
Clin. Cancer Res., March 1, 2002; 8(3): 636 - 640.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. S. Chuang, P. R. Kumaresan, and P. A. Mathew
2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-{gamma} Release in Human NK Cells Involves Distinct Pathways
J. Immunol., December 1, 2001; 167(11): 6210 - 6216.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Bulanova, V. Budagian, T. Pohl, H. Krause, H. Durkop, R. Paus, and S. Bulfone-Paus
The IL-15R{alpha} Chain Signals Through Association with Syk in Human B Cells
J. Immunol., December 1, 2001; 167(11): 6292 - 6302.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. M. Vyas, K. M. Mehta, M. Morgan, H. Maniar, L. Butros, S. Jung, J. K. Burkhardt, and B. Dupont
Spatial Organization of Signal Transduction Molecules in the NK Cell Immune Synapses During MHC Class I-Regulated Noncytolytic and Cytolytic Interactions
J. Immunol., October 15, 2001; 167(8): 4358 - 4367.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
B. S. Wilson, J. R. Pfeiffer, Z. Surviladze, E. A. Gaudet, and J. M. Oliver
High resolution mapping of mast cell membranes reveals primary and secondary domains of Fc{epsilon}RI and LAT
J. Cell Biol., August 6, 2001; 154(3): 645 - 658.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Jevremovic, D. D. Billadeau, R. A. Schoon, C. J. Dick, and P. J. Leibson
Regulation of NK Cell-Mediated Cytotoxicity by the Adaptor Protein 3BP2
J. Immunol., June 15, 2001; 166(12): 7219 - 7228.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Trotta, K. Fettucciari, L. Azzoni, B. Abebe, K. A. Puorro, L. C. Eisenlohr, and B. Perussia
Differential Role of p38 and c-Jun N-Terminal Kinase 1 Mitogen-Activated Protein Kinases in NK Cell Cytotoxicity
J. Immunol., August 15, 2000; 165(4): 1782 - 1789.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Peters, M. Tsuchida, E. R. Manthei, T. Alam, C. S. Cho, S. J. Knechtle, and M. M. Hamawy
Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506
Blood, May 1, 2000; 95(9): 2733 - 2741.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. D. Billadeau, S. M. Mackie, R. A. Schoon, and P. J. Leibson
Specific Subdomains of Vav Differentially Affect T Cell and NK Cell Activation
J. Immunol., April 15, 2000; 164(8): 3971 - 3981.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Gismondi, J. Jacobelli, F. Mainiero, R. Paolini, M. Piccoli, L. Frati, and A. Santoni
Cutting Edge: Functional Role for Proline-Rich Tyrosine Kinase 2 in NK Cell-Mediated Natural Cytotoxicity
J. Immunol., March 1, 2000; 164(5): 2272 - 2276.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
Z. Lou, D. Jevremovic, D. D. Billadeau, and P. J. Leibson
A Balance between Positive and Negative Signals in Cytotoxic Lymphocytes Regulates the Polarization of Lipid Rafts during the Development of Cell-mediated Killing
J. Exp. Med., January 17, 2000; 191(2): 347 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Colucci, M. Turner, E. Schweighoffer, D. Guy-Grand, V. Di Bartolo, M. Salcedo, V. L. J. Tybulewicz, and J. P. Di Santo
Redundant Role of the Syk Protein Tyrosine Kinase in Mouse NK Cell Differentiation
J. Immunol., August 15, 1999; 163(4): 1769 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Tridandapani, T. W. Lyden, J. L. Smith, J. E. Carter, K. M. Coggeshall, and C. L. Anderson
The Adapter Protein LAT Enhances Fcgamma Receptor-mediated Signal Transduction in Myeloid Cells
J. Biol. Chem., June 30, 2000; 275(27): 20480 - 20487.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jevremovic, D.
Right arrow Articles by Leibson, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jevremovic, D.
Right arrow Articles by Leibson, P. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS